Jeisys Medical Inc
KOSDAQ:287410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jeisys Medical Inc
Common Shares Outstanding
Jeisys Medical Inc
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Common Shares Outstanding
₩75.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Common Shares Outstanding
₩27.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Common Shares Outstanding
₩65.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
27%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Common Shares Outstanding
₩89.3m
|
CAGR 3-Years
146%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Common Shares Outstanding
₩57.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Common Shares Outstanding
₩37.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Common Shares Outstanding?
Common Shares Outstanding
75.5m
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Common Shares Outstanding amounts to 75.5m KRW.
What is Jeisys Medical Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
78%
Over the last year, the Common Shares Outstanding growth was -1%. The average annual Common Shares Outstanding growth rates for Jeisys Medical Inc have been 2% over the past three years , 78% over the past five years .